» Articles » PMID: 34351392

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021

Abstract

In a retrospective cohort study, among 131 773 patients with previous coronavirus disease 2019 (COVID-19), reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was suspected in 253 patients (0.2%) at 238 US healthcare facilities between 1 June 2020 and 28 February 2021. Women displayed a higher cumulative reinfection risk. Healthcare burden and illness severity were similar between index and reinfection encounters.

Citing Articles

Predicting higher risk factors for COVID-19 short-term reinfection in patients with rheumatic diseases: a modeling study based on XGBoost algorithm.

Liang Y, Xie S, Zheng X, Wu X, Du S, Jiang Y J Transl Med. 2024; 22(1):1144.

PMID: 39719617 PMC: 11668030. DOI: 10.1186/s12967-024-05982-2.


Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.

Zhu W, Tang X, Chen Y, Chen M, Han X, Xie Y Epidemiol Infect. 2024; 152:e144.

PMID: 39552127 PMC: 11574606. DOI: 10.1017/S0950268824001274.


A systematic literature review on public health and healthcare resources for pandemic preparedness planning.

Beishuizen B, Stein M, Buis J, Tostmann A, Green C, Duggan J BMC Public Health. 2024; 24(1):3114.

PMID: 39529010 PMC: 11552315. DOI: 10.1186/s12889-024-20629-z.


Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID.

Hadley E, Yoo Y, Patel S, Zhou A, Laraway B, Wong R Commun Med (Lond). 2024; 4(1):129.

PMID: 38992084 PMC: 11239932. DOI: 10.1038/s43856-024-00539-2.


A mini review of reinfection with the SARS-CoV-2 Omicron variant.

Shen H, Chen D, Li C, Huang T, Ma W Health Sci Rep. 2024; 7(4):e2016.

PMID: 38605725 PMC: 11007061. DOI: 10.1002/hsr2.2016.


References
1.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa M, Piumatti G . Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study. Clin Infect Dis. 2021; 74(4):622-629. PMC: 8241483. DOI: 10.1093/cid/ciab495. View

2.
Holm Hansen C, Michlmayr D, Gubbels S, Molbak K, Ethelberg S . Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021; 397(10280):1204-1212. PMC: 7969130. DOI: 10.1016/S0140-6736(21)00575-4. View

3.
Sheehan M, Reddy A, Rothberg M . Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study. Clin Infect Dis. 2021; 73(10):1882-1886. PMC: 7989568. DOI: 10.1093/cid/ciab234. View

4.
Qureshi A, Baskett W, Huang W, Lobanova I, Naqvi S, Shyu C . Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing. Clin Infect Dis. 2021; 74(2):294-300. PMC: 8135382. DOI: 10.1093/cid/ciab345. View

5.
Abu-Raddad L, Chemaitelly H, Malek J, Ahmed A, Mohamoud Y, Younuskunju S . Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin Infect Dis. 2020; 73(7):e1830-e1840. PMC: 7799253. DOI: 10.1093/cid/ciaa1846. View